Related Party Transactions (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Aug. 09, 2022	Apr. 15, 2021	Nov. 25, 2020
Aggregate number of common shares issued	20,011,602	9,625,133		6,666,666
Common stock shares issued price per share			$ 4.25	$ 3	$ 3.98
common stock shares authorized				300,000,000
Issued and outstanding shares of common stock ownership percentage				70.30%
Assets purchase agrement	$ 26,000,000			$ 20,000,000
Development expenses	6,845,964	$ 1,920,645
Total assets	37,109,014	40,822,161
Notes payble	884,000	213,405
Non convertivle notes payble	1,400,000
Product Co-development Agreement [Member]
Assets purchase agrement	29,542,959
Convertible	800,000	3,000,000
Development expenses	618,522	205,583
Accrued payables	70,113	65,156
Total assets	24,886,023
Equipment	1,113,977
Notes payble	376,526	505,931
Non convertivle notes payble	150,000	129,405
Accounts receivable	0	214,420
Ainos COVID-19 Test Kits Sales and Marketing Agreement with Ainos KY
Totaling	1,968,291	183,444
Accounts payable	24,365	0
COVID-19 Antigen Rapid Test Kits Sales
Totaling	2,855,205	209,468
Accounts receivable	177,795	0
Ase Test Inc. [Member]
Assets purchase agrement	26,000,000
Convertible	800,000	$ 3,000,000
Principal amount	$ 500,000